BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Osterman MT, Lichtenstein GR. Infliximab in fistulizing Crohn's disease. Gastroenterol Clin North Am. 2006;35:795-820. [PMID: 17129814 DOI: 10.1016/j.gtc.2006.09.007] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 1.1] [Reference Citation Analysis]
Number Citing Articles
1 Sninsky J, Barnes EL. Medical Management of Aggressive Inflammatory Bowel Disease: When Is the Time to Cut Your (and the Patient's) Losses? J Laparoendosc Adv Surg Tech A 2021;31:905-10. [PMID: 34171979 DOI: 10.1089/lap.2021.0338] [Reference Citation Analysis]
2 Hammami A, Slama AB, Jaziri H, Ameur WB, Mansour IB, Brahem A, Ajmi S, Jemni H, Ksiaa M, Jmaa A. Unusual case of duodenobiliary fistula complicating Crohn's disease successfully treated with Adalimumab. Arab J Gastroenterol 2016;17:188-90. [PMID: 27939339 DOI: 10.1016/j.ajg.2016.11.004] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
3 de Groof EJ, Buskens CJ, Ponsioen CY, Dijkgraaf MG, D'Haens GR, Srivastava N, van Acker GJ, Jansen JM, Gerhards MF, Dijkstra G, Lange JF, Witteman BJ, Kruyt PM, Pronk A, van Tuyl SA, Bodelier A, Crolla RM, West RL, Vrijland WW, Consten EC, Brink MA, Tuynman JB, de Boer NK, Breukink SO, Pierik MJ, Oldenburg B, van der Meulen AE, Bonsing BA, Spinelli A, Danese S, Sacchi M, Warusavitarne J, Hart A, Yassin NA, Kennelly RP, Cullen GJ, Winter DC, Hawthorne AB, Torkington J, Bemelman WA. Multimodal treatment of perianal fistulas in Crohn's disease: seton versus anti-TNF versus advancement plasty (PISA): study protocol for a randomized controlled trial. Trials 2015;16:366. [PMID: 26289163 DOI: 10.1186/s13063-015-0831-x] [Cited by in Crossref: 32] [Cited by in F6Publishing: 28] [Article Influence: 4.6] [Reference Citation Analysis]
4 Bemelman WA, Allez M. The surgical intervention: earlier or never? Best Pract Res Clin Gastroenterol. 2014;28:497-503. [PMID: 24913388 DOI: 10.1016/j.bpg.2014.04.013] [Cited by in Crossref: 20] [Cited by in F6Publishing: 15] [Article Influence: 2.5] [Reference Citation Analysis]
5 Lindsay JO, Chipperfield R, Giles A, Wheeler C, Orchard T; INDIGO study investigators. A UK retrospective observational study of clinical outcomes and healthcare resource utilisation of infliximab treatment in Crohn's disease. Aliment Pharmacol Ther 2013;38:52-61. [PMID: 23701393 DOI: 10.1111/apt.12339] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 1.7] [Reference Citation Analysis]
6 Orangio GR. Enterocutaneous fistula: medical and surgical management including patients with Crohn's disease. Clin Colon Rectal Surg 2010;23:169-75. [PMID: 21886466 DOI: 10.1055/s-0030-1262984] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 1.4] [Reference Citation Analysis]
7 Hamilton KE, Simmons JG, Ding S, Van Landeghem L, Lund PK. Cytokine induction of tumor necrosis factor receptor 2 is mediated by STAT3 in colon cancer cells. Mol Cancer Res 2011;9:1718-31. [PMID: 21994466 DOI: 10.1158/1541-7786.MCR-10-0210] [Cited by in Crossref: 36] [Cited by in F6Publishing: 24] [Article Influence: 3.3] [Reference Citation Analysis]
8 Jones DW, Finlayson SR. Trends in surgery for Crohn’s disease in the era of infliximab. Ann Surg. 2010;252:307-312. [PMID: 20585239 DOI: 10.1097/sla.0b013e3181e61df5] [Cited by in Crossref: 102] [Cited by in F6Publishing: 37] [Article Influence: 8.5] [Reference Citation Analysis]
9 Torkzad MR, Karlbom U. MRI for assessment of anal fistula. Insights Imaging. 2010;1:62-71. [PMID: 22347906 DOI: 10.1007/s13244-010-0022-y] [Cited by in Crossref: 30] [Cited by in F6Publishing: 19] [Article Influence: 2.5] [Reference Citation Analysis]
10 Nikfarjam M, Champagne B, Reynolds HL, Poulose BK, Ponsky JL, Marks JM. Acute Management of Stoma-Related Colocutaneous Fistula by Temporary Placement of a Self-Expanding Plastic Stent. Surg Innov 2009;16:270-3. [DOI: 10.1177/1553350609345851] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
11 Pachiadakis I, Nakos A, Tatsi P, Moschos J, Milias S, Nikolopoulos P, Balaris C, Apostolidis D, Zezos P. Simultaneous occurrence of hyperthyroidism and fistulizing Crohn's disease complicated with intra-abdominal fistulas and abscess: a case report and review of the literature. Cases J 2009;2:8541. [PMID: 19918383 DOI: 10.4076/1757-1626-2-8541] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
12 Judson MA. Allergic bronchopulmonary aspergillosis after infliximab therapy for sarcoidosis: a potential mechanism related to T-helper cytokine balance. Chest 2009;135:1358-9. [PMID: 19420205 DOI: 10.1378/chest.08-2106] [Cited by in Crossref: 18] [Cited by in F6Publishing: 13] [Article Influence: 1.4] [Reference Citation Analysis]
13 Kaliora AC, Stathopoulou MG, Triantafillidis JK, Dedoussis GV, Andrikopoulos NK. Alterations in the function of circulating mononuclear cells derived from patients with Crohn’s disease treated with mastic. World J Gastroenterol. 2007;13:6031-6036. [PMID: 18023095 DOI: 10.3748/wjg.13.6031] [Cited by in CrossRef: 20] [Cited by in F6Publishing: 15] [Article Influence: 1.4] [Reference Citation Analysis]
14 Kaliora AC, Stathopoulou MG, Triantafillidis JK, Dedoussis GV, Andrikopoulos NK. Alterations in the function of circulating mononuclear cells derived from patients with Crohn's disease treated with mastic. World J Gastroenterol 2007;13:6031-6. [PMID: 18023095 DOI: 10.3748/wjg.v13.45.6031] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 14] [Article Influence: 0.1] [Reference Citation Analysis]
15 Lippert E, Gunckel M, Brenmoehl J, Bataille F, Falk W, Scholmerich J, Obermeier F, Rogler G. Regulation of galectin-3 function in mucosal fibroblasts: potential role in mucosal inflammation. Clin Exp Immunol. 2008;152:285-297. [PMID: 18336593 DOI: 10.1111/j.1365-2249.2008.03618.x] [Cited by in Crossref: 29] [Cited by in F6Publishing: 27] [Article Influence: 2.1] [Reference Citation Analysis]
16 Kaliora AC, Stathopoulou MG, Triantafillidis JK, Dedoussis GV, Andrikopoulos NK. Alterations in the function of circulating mononuclear cells derived from patients with Crohn’s disease treated with mastic. World J Gastroenterol 2007; 13(45): 6031-6036 [DOI: 10.3748/wjg.v13.i45.6031] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
17 Carbone J, Gonzalez-Lara V, Sarmiento E, Chean C, Perez JL, Marin I, Rodríguez-Molina JJ, Gil J, Fernández-Cruz E. Humoral and cellular monitoring to predict the development of infection in Crohn's disease patients beginning treatment with infliximab. Ann N Y Acad Sci 2007;1107:346-55. [PMID: 17804562 DOI: 10.1196/annals.1381.036] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
18 Ponsky T, Hindle A, Sandler A. Inflammatory bowel disease in the pediatric patient. Surg Clin North Am. 2007;87:643-658. [PMID: 17560417 DOI: 10.1016/j.suc.2007.03.002] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis]